Cerebrospinal fluid NfL is a biomarker of neurodegeneration whose levels are elevated in AD and associate with central neuropathological changes–tauopathy, amyloidopathy and brain atrophy [6,7,8,9,10,16]. Here, NEFL is linked to Alzheimer disease.